Chronic Kidney Disease Trial, Recruiting NCT07222683 Sponsor: Brigham and Women's Hospital Condition: Chronic Kidney Disease
Back to Chronic Kidney Disease

Chronic Kidney Disease Trial, Recruiting

NCT07222683
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are waiting on a transplant list to receive a kidney
  • People aged 45 years or older, or people aged 18 to 44 years who have been on dialysis for 5 or more years

Who may not be able to join:

  • People whose heart is pumping at less than 40% of its normal capacity (confirm with trial site)
  • People who have previously had open-heart bypass surgery to improve blood flow to the heart
  • People who have previously received a heart transplant
  • People who have had a procedure to unblock or widen heart arteries as a result of a heart scan done before a kidney transplant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 8573074000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
10 March 2023
Est. completion
1 July 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Stress Myocardial Blood Flow (MBF); Myocardial Flow Reserve (MFR); Left ventricular global longitudinal strain (GLS, %); Left ventricular mitral inflow velocity to mitral annular early diastolic relaxation velocity ration (E/E'); Interleukin-6 (IL-6) levels; Vascular Endothelial Growth Factor A (VEGF-A); Angiopoeitin-1 (ANGPT1) Levels; Angiopoeitin-2 (ANGPT2) Levels

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov